1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in the United States, May 2019

Mental Health Analysis & Statistics in the United States, May 2019

1-30 of about 800 reports

Biomarkers in the Central Nervous System

Biomarkers in the Central Nervous System

  • $ 7995
  • Industry report
  • April 2019

Biomarkers in the Central Nervous SystemSummaryFinding a biomarker for Central Nervous System (CNS) disorders that translates into clinical meaningfulness has been a real challenge for the biomarkers ...

  • Industries : Genomics Proteomics and Enabling Technology, Mental Health, Biotechnology, Pathology
  • Countries : World, United States
Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030

Cell Encapsulation: Focus on Therapeutics and Technologies, 2019-2030

  • $ 4499
  • Industry report
  • March 2019

INTRODUCTIONChronic disorders, such as diabetes, cancer, heart disease, obesity, and certain types of mental health problems, are considered among the leading causes of death and disability across the ...

  • Industries : Pharmaceutical, Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pathology, Therapy
  • Countries : United States, North America, World
Global Amyotrophic Lateral Sclerosis Market Research Report - Forecast to 2023

Global Amyotrophic Lateral Sclerosis Market Research Report - Forecast to 2023

  • $ 4450
  • Industry report
  • March 2019

Global Amyotrophic Lateral Sclerosis Market Research Report - Forecast to 2023Amyotrophic Lateral Sclerosis Market Research Report: By Type (Familial ALS), by Treatment (Medication, Physical Therapy, Speech ...

  • Industries : Mental Health, Pharmaceutical, Therapy, Pathology
  • Countries : United States, North America, World
Global Myasthenia Gravis Market Research Report Forecast to 2023

Global Myasthenia Gravis Market Research Report Forecast to 2023

  • $ 4450
  • Industry report
  • March 2019

Myasthenia Gravis Market: By Type (Ocular Myasthenia Gravis, Congenital Myasthenia Gravis, Generalized Myasthenia Gravis, Transient Myasthenia Gravis, and Others), (Diagnosis and Treatment), End User (Hospitals ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, North America
Parkinson’s Disease Drugs Market - Growth, Trends, and Forecast (2019-2024)

Parkinson’s Disease Drugs Market - Growth, Trends, and Forecast (2019-2024)

  • $ 4250
  • Industry report
  • April 2019

Market OverviewParkinson’s disease is a chronic disorder that gradually leads to progressive deterioration of motor functions, caused by the loss of dopamine-producing brain cells. Parkinson’s disease ...

  • Industries : Mental Health, Pathology
  • Countries : United States, North America, World
Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • Industry report
  • May 2019

Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “Transmucosal Drug Delivery Devices - Medical Devices Pipeline Assessment, ...

  • Industries : Pharmaceutical
  • Countries : United States
Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • Industry report
  • May 2019

Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “Transdermal Drug Delivery Devices - Medical Devices Pipeline Assessment, ...

  • Industries : Pharmaceutical
  • Countries : United States
MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019

MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • Industry report
  • May 2019

MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “MRI (Magnetic Resonance Imaging) Systems - Medical Devices Pipeline ...

  • Industries : Diagnostic Imaging, Medical Device, Drug Development
  • Countries : United States
Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2019

Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • Industry report
  • March 2019

Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “Remote Patient Monitoring Devices - Medical Devices Pipeline Assessment, ...

  • Industries : Drug Development, Pharmaceutical, Healthcare, Patient Monitoring, E-Healthcare, E-Healthcare, Medical Device
  • Countries : United States
Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

Metabotropic Glutamate Receptor 2 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Metabotropic glutamate receptor 2 is a protein encoded by the GRM2 gene. ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World, United States
Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • May 2019

Metabotropic Glutamate Receptor 5 - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 5 (GPRC1E or MGLUR5 or GRM5) pipeline Target constitutes close to 23 molecules. Out of which approximately ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2019SummaryAlpha Synuclein (Non A Beta Component Of AD Amyloid or Non ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : United States
Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Pipeline Review, H1 2019SummaryNeuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) - Neuronal acetylcholine receptor subunit alpha-7 is a ...

  • Industries : Mental Health, Pathology, Pharmaceutical, Therapy
  • Countries : United States, World
Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Glutamate Receptor Ionotropic NMDA 2B (Glutamate [NMDA] Receptor Subunit Epsilon 2 or N Methyl D Aspartate Receptor Subtype 2B or N Methyl D Aspartate Receptor Subunit 3 or GRIN2B) - Pipeline Review, H1 ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States
Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • April 2019

Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H1 2019SummaryAccording to the recently published report ’Survival Motor Neuron Protein - Pipeline Review, ...

  • Industries : Therapy, Pharmaceutical, Mental Health
  • Countries : United States, World
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2019SummaryIntegrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha o ...

  • Industries : Therapy, Pathology, Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Oncology
  • Countries : World, United States
Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019

  • $ 3500
  • Company report
  • March 2019

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2019SummaryMetabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Metabotropic glutamate receptor 4 is a protein ...

  • Industries : Mental Health, Therapy, Pathology, Pharmaceutical
  • Countries : Switzerland, World, United States
Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2019

Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2019

  • $ 2500
  • Industry report
  • May 2019

Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2019SummaryGlobalData’s Medical Devices sector report, “Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2019" provides ...

  • Industries : Pharmaceutical, Drug Delivery, Therapy, Drug Development
  • Countries : United States
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Attention Deficit Hyperactivity Disorde ...

  • Industries : Mental Health, Pathology, Pharmaceutical, Therapy
  • Countries : United States
Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Diabetic Peripheral Neuropathy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Peripheral Neuropathy - Pipeline Review, H1 ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States
Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Spinal Muscular Atrophy (SMA) - Pipeline Review, H1 ...

  • Industries : Mental Health, Pathology
  • Countries : United States
Drug Addiction - Pipeline Review, H1 2019

Drug Addiction - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Drug Addiction - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2019, provides an overview of ...

  • Industries : Mental Health, Pathology, Therapy, Pharmaceutical
  • Countries : United States
Autism - Pipeline Review, H1 2019

Autism - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Autism - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Autism - Pipeline Review, H1 2019, provides an overview of the Autism (Central ...

  • Industries : Mental Health, Pathology, Health Services, Healthcare, Pharmaceutical, Therapy
  • Countries : United States
Down Syndrome - Pipeline Review, H1 2019

Down Syndrome - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Down Syndrome - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Down Syndrome - Pipeline Review, H1 2019, provides an overview of the ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States
Traumatic Brain Injury - Pipeline Review, H1 2019

Traumatic Brain Injury - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • April 2019

Traumatic Brain Injury - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Traumatic Brain Injury - Pipeline Review, H1 2019, provides ...

  • Industries : Pathology, Mental Health
  • Countries : United States
Fabry Disease - Pipeline Review, H1 2019

Fabry Disease - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Fabry Disease - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Fabry Disease - Pipeline Review, H1 2019, provides an overview of the ...

  • Industries : Therapy, Pathology, Pharmaceutical, Medical Biotechnology, Healthcare
  • Countries : United States
Becker Muscular Dystrophy - Pipeline Review, H1 2019

Becker Muscular Dystrophy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Becker Muscular Dystrophy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Becker Muscular Dystrophy - Pipeline Review, H1 2019, provides ...

  • Industries : Therapy, Mental Health, Pathology, Pharmaceutical
  • Countries : United States, World
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Chemotherapy Induced Peripheral Neuropathy ...

  • Industries : Therapy, Pathology, Mental Health, Oncology, Pharmaceutical
  • Countries : United States
Duchenne Muscular Dystrophy - Pipeline Review, H1 2019

Duchenne Muscular Dystrophy - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Duchenne Muscular Dystrophy - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H1 2019, ...

  • Industries : Pathology, Mental Health, Therapy, Pharmaceutical
  • Countries : United States
Urinary Incontinence - Pipeline Review, H1 2019

Urinary Incontinence - Pipeline Review, H1 2019

  • $ 2000
  • Company report
  • March 2019

Urinary Incontinence - Pipeline Review, H1 2019SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H1 2019, provides an ...

  • Industries : Pharmaceutical, OTC
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on